EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
11 hedge funds and large institutions have $15.3M invested in ESSA Pharma in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.25%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
3
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
+$5.97M |
2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$3.8M |
3 |
BI
BVF Inc
San Francisco,
California
|
+$1.94M |
4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.31M |
5 |
UBS Group
Zurich,
Switzerland
|
+$4.44K |
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10K |
2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$110 |